Status:
COMPLETED
Ergogenic Properties of Magnesium Supplementation
Lead Sponsor:
Christopher Bell
Conditions:
Exercise Performance
Gut -Microbiota
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The purpose of the proposed project is to determine if short-term dietary supplementation of magnesium will improve performance during a series of lab-based exercise tests, will favorably modify the g...
Detailed Description
Magnesium is the fourth most abundant mineral in the human body. It is critical to day-to-day physiological function including the regulation of metabolism, cardiovascular function, immune function, a...
Eligibility Criteria
Inclusion
- Competitive cyclists
- Adult males and females (18 - 40 years, inclusive) who have exercised a minimum of 5 days per week, for a minimum of 30-minutes/session, during the previous 2 years.
- Maximal oxygen uptake (VO2max) satisfying the minimum criteria for "Good" (sex- and age-adjusted) as defined by the American College of Sports Medicine.
Exclusion
- Identification of a contra-indication to exercise during a 12-lead exercise stress test
- Use of a magnesium supplement within the previous 4 weeks
- Pregnancy or breast-feeding
- Unable to perform vigorous exercise
- History (previous diagnosis) of kidney disease
- Use of laxatives, Zinc, diuretics, proton pump inhibitors, over the counter agents such as certain heartburn and GI/gut treatments (laxatives) which contain magnesium, Zinc or other high dose cations which reduce absorption of Magnesium
Key Trial Info
Start Date :
December 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05282693
Start Date
December 17 2021
End Date
February 28 2024
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Colorado State University, Dept. of Health and Exercise Science
Fort Collins, Colorado, United States, 80523-1582